ACTIVE

TRIPLE AAA

Financial year 2025 · closed on 31/12/2025
Net result
-14,3 k €
-140.6% YoY
Gross margin
227,3 k €
-21.6% YoY
Equity
148,4 k €
-28.8% YoY
Workforce
3,0 ETP
0.0% YoY

What does TRIPLE AAA do?

TRIPLE AAA is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Evere. It employs on average 3,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0839.714.053
Incorporation
28/09/2011
Legal form
Private limited company
Registered office
Chaussée de Haecht 1019
1140 Evere · BruxellesSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Average workforce
3,0 ETP
Signals
Low riskPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 8 financial years

20252024202320222021201420132012
Income statement
Gross margin227,3 k €290 k €329 k €287,2 k €245,4 k €235,1 k €207,5 k €252,5 k €
EBITDA14,3 k €83,5 k €154,8 k €146,7 k €89,7 k €190,3 k €170,7 k €163,5 k €
Operating result-1,6 k €69,5 k €132,3 k €107,9 k €43,6 k €138,1 k €127,3 k €131,4 k €
Net result-14,3 k €35,3 k €77,7 k €72,9 k €15,8 k €78,8 k €81,9 k €80,2 k €
Balance sheet
Equity148,4 k €208,4 k €173,1 k €139 k €117,1 k €260,9 k €182,1 k €100,2 k €
Total assets532,5 k €603,2 k €625,8 k €715,2 k €663,4 k €941,9 k €909,4 k €605,2 k €
Cash115,8 k €152,7 k €174,3 k €207 k €193,6 k €181,2 k €171,5 k €104,6 k €
Debts365,8 k €393,4 k €444,9 k €570,6 k €534,2 k €675,5 k €726,8 k €505 k €
Other
Workforce3,0 ETP3,0 ETP2,6 ETP2,9 ETP2,9 ETP1,0 ETP1,0 ETP1,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 5 ended

Active mandates

PHARMALEC

Bestuurder · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Active

Ended mandates

PHARMALEC

Director · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Ended
PHARMALEC

Manager · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Ended
Pharmalec BV

Bestuurder · since 01 octobre 2017

Represented by Andreas Ghijselings

Ended
Andreas Ghijselings

Manager · since 26 novembre 2011

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/08/202630/06/202528/06/202418/07/202307/06/202227/07/2021
General meeting29/05/202630/05/202531/05/202426/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

14 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202603/08/2026DutchPDF
Abridged model31/12/202430/05/202530/06/2025DutchPDF
Abridged model31/12/202331/05/202428/06/2024DutchPDF
Abridged model31/12/202226/05/202318/07/2023DutchPDF
Abridged model31/12/202127/05/202207/06/2022DutchPDF
Abridged model31/12/202028/05/202127/07/2021DutchPDF
Abridged model31/12/201929/05/202026/06/2020DutchPDF
Abridged model31/12/201831/05/201905/08/2019DutchPDF
Abridged model31/12/201725/05/201825/06/2018DutchPDF
Abridged model31/12/201626/05/201728/07/2017DutchPDF
Abridged model31/12/201527/05/201631/08/2016DutchPDF
Abridged model31/12/201428/08/201531/08/2015DutchPDF
Abridged model31/12/201322/07/201430/07/2014DutchPDF
Abridged model31/12/201229/08/201331/08/2013DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 5 ended

Active mandates

PHARMALEC

Bestuurder · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Active

Ended mandates

PHARMALEC

Director · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Ended
PHARMALEC

Manager · since 01 octobre 2017 · 0678.956.844

Represented by Andreas Ghijselings

Ended
Pharmalec BV

Bestuurder · since 01 octobre 2017

Represented by Andreas Ghijselings

Ended
Andreas Ghijselings

Manager · since 26 novembre 2011

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates20/12/2023
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/01/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office10/04/2015
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other10/10/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-14,3 k €
  2. 2024
    Annual accounts 202435,3 k €
  3. 2023
    Annual accounts 202377,7 k €
  4. 2022
    Annual accounts 202272,9 k €
  5. 2021
    Annual accounts 202115,8 k €
  6. 2014
    Annual accounts 201478,8 k €
  7. 2013
    Annual accounts 201381,9 k €
  8. 2012
    Annual accounts 201280,2 k €
  9. 28/09/2011
    IncorporationPrivate limited company